308 related articles for article (PubMed ID: 29101123)
21. MicroRNA-146a modulates TGF-β1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4.
Liu Z; Lu CL; Cui LP; Hu YL; Yu Q; Jiang Y; Ma T; Jiao DK; Wang D; Jia CY
Arch Dermatol Res; 2012 Apr; 304(3):195-202. PubMed ID: 21968601
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
He Y; Huang C; Sun X; Long XR; Lv XW; Li J
Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
[TBL] [Abstract][Full Text] [Related]
24. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
25. Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves' ophthalmopathy.
Li K; Du Y; Jiang BL; He JF
Med Sci Monit; 2014 Apr; 20():639-43. PubMed ID: 24743332
[TBL] [Abstract][Full Text] [Related]
26. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
[TBL] [Abstract][Full Text] [Related]
27. miR-146a-5p acts as a negative regulator of TGF-β signaling in skeletal muscle after acute contusion.
Sun Y; Li Y; Wang H; Li H; Liu S; Chen J; Ying H
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):628-634. PubMed ID: 28510617
[TBL] [Abstract][Full Text] [Related]
28. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.
Xu Z; Ramachandran S; Gunasekaran M; Zhou F; Trulock E; Kreisel D; Hachem R; Mohanakumar T
J Heart Lung Transplant; 2015 Sep; 34(9):1154-62. PubMed ID: 25979625
[TBL] [Abstract][Full Text] [Related]
30. The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease.
Xie B; Xiong W; Zhang F; Wang N; Luo Y; Chen Y; Cao J; Chen Z; Ma C; Chen H
Mol Cell Endocrinol; 2023 Jan; 559():111780. PubMed ID: 36179941
[TBL] [Abstract][Full Text] [Related]
31. TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.
Woeller CF; Roztocil E; Hammond C; Feldon SE
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4336-4345. PubMed ID: 31622470
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.
Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC
Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648
[No Abstract] [Full Text] [Related]
33. Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
Kau HC; Wu SB; Tsai CC; Liu CJ; Wei YH
Oxid Med Cell Longev; 2016; 2016():4676289. PubMed ID: 27340508
[TBL] [Abstract][Full Text] [Related]
34. Autophagy is involved in the initiation and progression of Graves' orbitopathy.
Yoon JS; Lee HJ; Chae MK; Lee EJ
Thyroid; 2015 Apr; 25(4):445-54. PubMed ID: 25687157
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
[TBL] [Abstract][Full Text] [Related]
36. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee CE; Choi SH; Yoon JS
Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy.
Kozdon K; Fitchett C; Rose GE; Ezra DG; Bailly M
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5743-50. PubMed ID: 26325413
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of MicroRNA-146a/Notch2 Signaling Regulating IL-6 in Graves Ophthalmopathy.
Wang N; Chen FE; Long ZW
Cell Physiol Biochem; 2017; 41(4):1285-1297. PubMed ID: 28278511
[TBL] [Abstract][Full Text] [Related]
39. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy.
Kim BR; Kim J; Lee JE; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):39. PubMed ID: 32196098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
